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Methicillin-resistant  Staphylococcus aureus (MRSA)
was isolated from nares of 27/417 (6.5%) attendees at an
international veterinary conference: 23/345 (7.0%) veteri-
narians, 4/34 (12.0%) technicians, and 0/38 others.
Colonization was more common for large-animal (15/96,
15.6%) than small-animal personnel (12/271, 4.4%) or
those with no animal patient contact (0/50) (p<0.001).
Large-animal practice was the only variable significantly
associated with colonization (odds ratio 2.9; 95% confi-
dence interval 1.2–6.6). Pulsed-field gel electrophoresis
identified 2 predominant clones with similar distribution
among veterinarians as previously reported for horses and
companion animals. Canadian epidemic MRSA-2
(CMRSA) was isolated from 11 small-animal and 2 large-
animal personnel from the United States (n = 12) and
Germany (n = 1). In contrast, CMRSA-5 was isolated exclu-
sively from large-animal personnel (p<0.001) in the United
States (n = 10), United Kingdom (n = 2), and Denmark (n =
1). MRSA colonization may be an occupational risk for vet-
erinary professionals.
M
ethicillin-resistant  Staphylococcus aureus (MRSA)
is a problematic pathogen in human medicine and
appears to be an emerging problem in veterinary medicine.
Historically, hospital-associated MRSA infections have
predominated in humans and contributed to significant ill-
ness and death (1–4). Recently, a shift in the epidemiology
of MRSA infection has been documented, whereby com-
munity-associated (CA)-MRSA infections have become
more common (5–9). CA-MRSA may arise from hospital-
origin clones that are carried into the community and then
transmitted between persons or from de novo development
of resistance through acquisition of resistance factors
(mecA) by methicillin-sensitive strains of S. aureus (10).
Asymptomatic colonization with MRSA represents a
major risk factor for infection or for transmission among
persons within hospitals or the community (11).
While CA-MRSA infections are becoming more wide-
ly reported, the prevalence of MRSA carriage overall
remains low in healthy persons in the community
(6,12–14). Reported prevalence of MRSA colonization in
the community has been variable; the study population has
a major effect on MRSA carriage rates. In the absence of
recognized risk factors, the prevalence of colonization
tends to be low. In a 2003 study, Salgado et al. identified
MRSA colonization in 1.3% of persons overall but in only
0.2% of persons with no identified healthcare-associated
risk factors (12). A study from Switzerland reported
MRSAcolonization in 0.09% of persons at the time of hos-
pital admission (6). The prevalence of MRSAcarriage was
0.3% in a 2005 study that Nulens et al. conducted at a
European conference for physicians and others involved in
clinical microbiology and infectious disease (15).
MRSAinfection and colonization have been reported in
horses, dogs, cats, birds, and cattle (16–19). Transmission
of MRSA between animals and humans has been reported
(20–23) as have human MRSA infections from animal
contact (16,21,24). Recent studies have identified high col-
onization rates in humans who have close contact with ani-
mals. MRSA colonization of persons who work with
horses in Canada and the United States was 13% (14/107);
on every farm where MRSA was identified in a horse, at
least 1 person was colonized (25). In another study, 10
(9.7%) of 103 tested veterinary hospital personnel in a
large-animal clinic were colonized with MRSA, and clini-
cal skin infections were reported in 3 (26). Isolates from
horses and humans in each of these studies were indistin-
guishable by pulsed-field gel electrophoresis (PFGE) and
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Canadawere typed as Canadian epidemic MRSA (CMRSA)-5
(ST8:MRSA:SCCmecIV, also known as USA500), which
suggests transmission between horses and humans (27). A
study at a small-animal referral hospital in the United
Kingdom reported MRSAcolonization in 17.9% of veteri-
nary personnel. Investigation of clinical infection in 5 dogs
and 3 cats found colonization in 14 (16%) of 88 household
contacts or veterinary personnel (28). In all of the above
reports, a screening bias for MRSAcolonization may have
been present if an outbreak had been ongoing in the popu-
lation. Whether these results would accurately reflect the
prevalence of MRSA in the general veterinary population,
and therefore the occupational risk of MRSA exposure for
veterinarians, is unclear. Our objective was to determine
the prevalence of MRSA colonization in veterinary per-
sonnel attending an international veterinary conference
and to characterize recovered MRSA isolates.
Materials and Methods
Study Population
This study was performed at the annual American
College of Veterinary Internal Medicine Forum held in
Baltimore, Maryland, USA, June 3–5, 2005. The confer-
ence was attended by 3,240 persons: 2,744 practicing vet-
erinarians, 354 technicians, and 142 other veterinary
personnel involved in industry or research. Most (86%)
attendees were from the United States; however, 43 other
countries were represented. An information and sampling
booth attended by the investigators was used to enroll adult
volunteers; all attendees were eligible. This study was
approved by the University of Guelph Research Ethics
Board.
Sample Collection 
Participants provided a single nasal swab sample each,
which they collected themselves according to instructions
to insert a cotton-tipped swab ≈1 cm into each nostril. The
swabs were placed in liquid Stuart medium and maintained
at 4°C until processing.
Participants completed a brief questionnaire designed
to identify potential risk factors for MRSA colonization:
nationality, occupational position, type of clinical practice,
veterinary patient contact, known exposure to MRSA in
veterinary practice, previous hospitalization (within 30
days), previous MRSA infection, and residence with a
healthcare worker. Practice types were small-animal (pri-
marily dogs and cats), large-animal (primarily horses but
also ruminants), and mixed (combination of large and
small animals). We defined CA-MRSA colonization as
MRSA isolation from a person with no history of health-
care-associated risk factors.
MRSA Identification, Characterization, and Typing
Swabs were placed into 2 mL of enrichment broth con-
sisting of 10 g/LTryptone T (Oxoid Inc., Nepean, Ontario,
Canada), 75 g/L sodium chloride, 10 g/L mannitol, and 2.5
g/L yeast extract and incubated for 24 h at 35°C.
Approximately 100 µL of broth was spread onto mannitol-
salt agar with 10 g/L cefoxitin and incubated at 35°C for
48 h. Isolates were identified as S. aureus on the basis of
colony morphologic features, gram-positive stain, cata-
lase-positive reaction, positive tube coagulase test result,
and positive latex agglutination test result (Pastorex Staph
Plus, Bio-Rad Laboratories Ltd, Mississauga, Ontario,
Canada). Methicillin-resistance was confirmed by demon-
stration of penicillin binding protein 2a with a latex agglu-
tination antibody screening kit (Denka Seinken Co. Ltd,
Tokyo, Japan). Antimicrobial susceptibility was performed
by Kirby-Bauer disk diffusion according to the Clinical
Laboratory Standards Institute (CLSI) guidelines (29);
mupirocin MIC was determined by using E-Test gradient
strips (AB Biodisk, Solna, Sweden). MRSA isolates were
typed by SmaI PFGE and categorized as different
CMRSAtypes as described previously (8). Real-time PCR
was used to detect the lukF and lukS components of the
Panton-Valentine leukocidin (PVL) gene previously
described (30).
Statistical Analysis
Categorical comparisons were performed using χ2
analysis or Fisher exact test. A p value <0.05 was consid-
ered significant for all comparisons. Risk factors for
MRSA colonization were evaluated by using stepwise for-
ward logistic regression. Variables achieving a liberal sig-
nificance level of p<0.20 in the univariate analyses were
considered for inclusion in the multivariate model. The
presence of confounding was evaluated by noting the
effect of elimination on the coefficients of the remaining
variables. Variables achieving p<0.05 in the final model
were considered significant, and odds ratios (ORs) with
95% confidence intervals (CIs) were calculated.
Results
Nasal swabs were provided by 417 attendees from 19
countries. MRSAwas isolated from the nasal cavities of 27
(6.5%) of 417 persons: 15 (15.6%) of 96 in large-animal
practice, 12 (4.4%) of 271 in small-animal practice, and 0
of 50 in industry or research (p<0.001) (Table 1). The
prevalence of colonization was higher in men (13/139,
9.4%) than in women (14/265, 5.3%); however, this differ-
ence was not statistically significant (p = 0.09).
Colonized persons were from the United States (n =
23), United Kingdom (n = 2), Denmark (n = 1), and
Germany (n = 1). Difference in the prevalence of coloniza-
tion between countries was not significant (p = 0.18).
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Canada, and the United Kingdom—the 3 countries with
the highest representation—were 6.0%, 0%, and 17%,
respectively (p = 0.11). According to stepwise forward
logistic regression, employment in a large-animal practice
was the only variable independently associated with
MRSA colonization (OR 2.9; 95% CI 1.2–6.6).
Characterization of MRSA isolates, using PFGE, iden-
tified 2 predominant clones: CMRSA-5 (ST8-MRSA-IV,
similar to USA500) and CMRSA-2 (ST5-MRSA-II, simi-
lar to USA100) (8,31). CMRSA-5 was isolated from 13
(48%) of 27 colonized persons, all of whom were in large-
animal practice. These persons were from the United
States (n = 10), United Kingdom (n = 2), and Denmark (n
= 1). CMRSA-2 was isolated from 13 (48%) of 27 colo-
nized persons: 11 in small-animal practice and 2 in large-
animal practice from the United States (n = 12) and
Germany (n = 1). One other isolate, possibly related to
CMRSA-2, was recovered from a US veterinarian in
small-animal practice. Overall, CMRSA-5 was more com-
monly isolated from persons in large- than in small-animal
practice (p<0.001). A cluster of 5 colonized persons was
identified from a US school of veterinary medicine, where
4 persons who worked with large animals were colonized
with CMRSA-5, and 1 veterinarian who worked with
small animals was colonized with CMRSA-2. No isolates
were identified as carrying the lukF or lukS genes. All iso-
lates were susceptible to vancomycin; other antimicrobial
drug susceptibility results are shown in Table 2.
Discussion
This study represents the most comprehensive evalua-
tion to date of MRSAcolonization in veterinary personnel.
Although a control group was not included, the prevalence
in veterinary personnel (6.5%) was higher than previously
reported rates for community-based colonization
(6,12–14,32). When compared with results from a similar
study in which only 0.3% of medical professionals at a
conference were colonized (15), our results suggest an
increased risk for veterinary professionals. However, geo-
graphic location and culture methods may have affected
the differences in study results, and further investigation is
required to more accurately define the occupational risk.
The PFGE type distribution provides support that
MRSA is being transmitted between animals and humans.
A significant difference was identified between clones
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(CMRSA-5) and those who worked with small animals
(CMRSA-2). If these results merely represented the back-
ground level of CA-MRSA colonization in the general
population, this difference would not be expected. In addi-
tion, CMRSA-5 has not been commonly identified in per-
sons in the community, at least not in Canada (8,33),
although it has accounted for most of the reported cases of
MRSA infection or colonization in horses (16,24,27).
These findings, along with the identification of CMRSA-5
in large-animal veterinarians from the United States,
United Kingdom, and Denmark, provide further evidence
that CMRSA-5 is widely disseminated in the horse popu-
lation and may be transmitted between horses and humans.
The CMRSA-5 isolate from the Danish veterinarian was
further classified as sequence type 8 and Ridom spa type
t064, which has been identified in humans in Denmark,
Norway, Germany, Belgium, and Sweden (R. Skov, pers.
comm.). CMRSA-5 predominance in large-animal veteri-
narians may infer an occupational health concern for vet-
erinary professionals who have contact with equine
patients. Furthermore, this study’s finding of large-animal
practice as the only variable associated with colonization
and the striking prevalence of MRSA colonization in per-
sons who work with large animals (15.6%) also support an
occupational risk for MRSA exposure in large-animal
practice. Because zoonotic infections have been associated
with exposure to CMRSA-5 (26), further evaluation of
interspecies transmission within large-animal veterinary
practices by routine screening of patients and personnel,
along with implementation of infection control practices,
may be warranted.
Identification of CMRSA-2 primarily in small-animal
veterinarians was consistent with previous reports that
MRSA isolates from dogs and cats reflect the predominant
human strains in the community (17,22). In Canada,
CMRSA-2 is a hospital-origin clone that has emerged in the
community as a major cause of CA-MRSA infections in
people (33,34). The lower prevalence of colonization in
persons who work with small animals and the predomi-
nance of a common community clone make it more diffi-
cult to implicate animal contact as the source of MRSA.
However, because colonization in persons who work with
small animals was higher than community prevalence rates
and because MRSA transmission from household pets to
humans has been reported (20,21), dogs and cats must be
considered as possible sources of MRSA. Acomprehensive
evaluation of MRSAcolonization in small animals and risk
factors for interspecies transmission are required to deter-
mine the true occupational risk for MRSAcolonization and
infection in small-animal veterinary personnel (17,18).
Although CA-MRSA isolates that express the PVL
genes are frequently a cause of severe skin and soft tissue
infections in the community (8,9,35–37), this virulence
factor was not identified in isolates from veterinary per-
sonnel. These results are similar to those of previous stud-
ies in which MRSA isolates from veterinary species or
personnel have been negative for PVL genes
(24,26,28,38). However, considering the recent dissemina-
tion of the PVL-positive USA300 clone throughout North
America and that MRSA isolates in dogs and cats often
reflect the predominant community clones, PVL-positive
clones may emerge in small animals (36). Further monitor-
ing of the dynamic epidemiology of CA-MRSAis required
to determine whether animals will have any role in dissem-
ination of this clone.
Previous contact with MRSAin a colonized or infected
animal was reported by 6.9% of colonized persons but was
not significantly associated with MRSA colonization in
veterinary personnel. The number of personnel reporting
previous contact with an infected animal was low, thereby
limiting the ability of this study to identify an association.
Intuitively, one would assume that contact with MRSA-
infected animals in veterinary practice would represent a
high-risk situation; further investigation is required to
more accurately determine this risk.
This study has several limitations. First, the sample
used was a convenience sample of attendees at the Forum,
which allows potential sample bias. Second, a greater pro-
portion of veterinary personnel sampled were in specialty
practice, leading to results that, because of different patient
populations, may not apply to general practitioners. Third,
because this was a cross-sectional study, causality between
risk factors and colonization could not be determined; only
an association between variables and colonization could be
implied. The small sample size from several countries also
limited the statistical power to identify an association in
these populations. Lastly, because attendees collected their
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underestimation of the prevalence of colonization. The
variable sensitivity (75%–93%) of using nasal swab
screening alone (39) could also have led to false-negative
results. Ideally, a randomized sample of general and spe-
cialty practitioners would be performed using >1 sampling
site to further characterize the prevalence of MRSA colo-
nization in veterinary personnel.
As MRSA expands into the community, changes in its
epidemiology are inevitable. The lives of humans and ani-
mals, and their microflora, are closely intertwined. MRSA
is now a pathogen of domestic animals that can be trans-
mitted between animals and humans. Accordingly, further
scrutiny of the roles of animals in MRSAinfection and col-
onization is required. While occupational and recreational
exposure to horses may be a risk factor for MRSA colo-
nization, the effect of routine contact with household pets
on the global epidemiology of MRSA is still unknown.
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